Department of Anatomy and Neurosciences, Section Functional Neuroanatomy, Neuroscience Campus Amsterdam, VU University Medical Center Amsterdam, the Netherlands.
Brain Pathol. 2012 Jul;22(4):485-98. doi: 10.1111/j.1750-3639.2011.00540.x. Epub 2011 Nov 8.
The locus ceruleus is among the earliest affected brain regions in Parkinson's disease (PD) showing Lewy body pathology and neuronal loss. To improve our understanding of the pathogenesis of PD, we performed the first proteomic analysis ever of post-mortem locus ceruleus tissue of six pathologically confirmed PD patients, and six age- and gender-matched non-neurological controls. In total 2495 proteins were identified, of which 87 proteins were differentially expressed in the locus ceruleus of PD patients compared with controls. The majority of these differentially expressed proteins are known to be involved in processes that have been implicated in the pathogenesis of PD previously, including mitochondrial dysfunction, oxidative stress, protein misfolding, cytoskeleton dysregulation and inflammation. Several individual proteins were identified that have hitherto not been associated with PD, such as regucalcin, which plays a role in maintaining intracellular calcium homeostasis, and isoform 1 of kinectin, which is involved in transport of cellular components along microtubules. In addition, pathway analysis suggests a pathogenetic role for aminoacyl-tRNA-biosynthesis. These findings indicate that the proteome of the locus ceruleus of PD patients and non-neurological controls provides data that are relevant to the pathogenesis of PD, reflecting both known and potentially novel pathogenetic pathways.
蓝斑是帕金森病 (PD) 最早受影响的大脑区域之一,表现为路易体病理和神经元丧失。为了提高我们对 PD 发病机制的理解,我们对六位经病理证实的 PD 患者和六位年龄和性别匹配的非神经科对照者死后蓝斑组织进行了首次蛋白质组学分析。总共鉴定出 2495 种蛋白质,其中 87 种蛋白质在 PD 患者的蓝斑中与对照组存在差异表达。这些差异表达的蛋白质中的大多数已知与 PD 的发病机制有关,包括线粒体功能障碍、氧化应激、蛋白质错误折叠、细胞骨架失调和炎症。还鉴定出了一些以前与 PD 无关的个别蛋白质,例如参与维持细胞内钙稳态的调节钙蛋白和参与沿微管运输细胞成分的动力蛋白同工型 1。此外,途径分析表明,氨基酸酰-tRNA 合成具有致病作用。这些发现表明,PD 患者和非神经科对照者蓝斑的蛋白质组提供了与 PD 发病机制相关的数据,反映了已知和潜在的新发病途径。